                         SEQUENCE LISTING

<110>  BioVentures, LLC
       Frett, Brendan
       Kendrick, Samantha
 
<120>  NEK2 PROTEOLYSIS TARGETING CHIMERAS

<130>  169852.00082

<150>  US 63/046,209
<151>  2020-06-30

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic - Consensus motif for altered phosphorylation sites 
       shown in Figure 10D


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  X is S, R, L, E, P, K, G, Q, T, A, V, F, I, Y, D, N, M, or H

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  X is S, R, K, A, E, D, P, G, L, Q, V, T, N, Y, I, or H

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  X is R, S, E, G, A, K, P, D, V, T, L, Q, H, or N

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  X is S, P, E, T, G, R, A, D, K, Q, L, V, M, F, I, or N

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  X is S, L, D, G, A, E, P, R, T, V, Q, N, M, K, or T

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  X is S or T

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  X is P, D, S, E, G, T, L, Q, N, or A

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  X is E, S, G, D, P, A, T, Q, K, L, R, V, or N

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  X is E, S, K, P, G, R, T, D, A, Q, L, V, I, N, or M

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  X is S, K, E, A, G, D, P, Q, R, L, V, T, I, F, Y, M, or W

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  X is E, S, K, R, A, P, G, L, D, T, V, Q, I, N, M, or Y

<400>  1

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10      


